Ischemic stroke. Cerebellar stroke syndrome
Conditions
Interventions
Intervention 1: Intervention group: Patients in the intervention group will receive a combined treatment of aspirin 80 mg and cilostazol 200 mg orally daily for 3 months. Intervention 2: Control group
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age 18 years and older Non-cardioembolic stroke Having a score of less than 20 on the National Institutes of Health Stroke Scale (NIHSS) and a score of 0-2 on the Modified Rating Scale (MRS)
Exclusion criteria
Exclusion criteria: Antiplatelet use including cilostazol, clopidogrel, ticlopidine, aspirin more than 200 mg or any type of anticoagulant before the onset of stroke Bleeding or tendency to bleed Congestive heart failure Malignancy Allergy to cilostazol or salicylic acid or aspirin-induced asthma History of cerebral hemorrhage Platelets less than 10,000 Pregnancy or breastfeeding History of recent gastric ulcer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIHSS score (National Institutes of Health Stroke Scale) as a measure of the amount of disturbance caused in stroke. Timepoint: Before and 3 months after the intervention. Method of measurement: Questionnaire.;MRS score (Modified Rankin Scale). Timepoint: Before and 3 months after the intervention. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cerebral hemorrhage. Timepoint: 3 months after the intervention. Method of measurement: MRI. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Fatemeh Hamzeh
Oroumia University of Medical Sciences
Outcome results
None listed